Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jul 29, 2009

University of Queensland to Use Life Technologies Instrumentation for Cancer Research

  • The University of Queensland’s Institute for Molecular Bioscience (IMB) and Life Technologies will collaborate to study pancreatic and ovarian cancer in Australia.

    Researchers will use Applied Biosystems’ (part of Life Technologies) SOLiD system for the genomic analysis of pancreatic and ovarian tumors.
    Through this collaboration, IMB will acquire nine new SOLiD systems for a total of 11 instruments. IMB is deploying SOLiD sequencing technology for its participation in the International Cancer Genome Consortium (ICGC).



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »